Press release
Macular Degeneration Treatment Global Market Forecast 2023-2032 : By Industry Analysis, Size, Share, Major Players Are - Novartis AG, Regenxbio Inc., GlaxoSmithKline plc, Bayer AG, StemCells Inc.
Macular Degeneration Treatment Market Analysis
As per the macular degeneration treatment market report by The Business Research Company, The increasing burden of retinal disorders is expected to propel the growth of the macular degeneration treatment market. Retinal disorders affect the vital tissue and affect the way individuals process visual information, leading to distorted or absent vision.
The global macular degeneration treatment market size grew from $8.44 billion in 2022 to $9.43 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The macular degeneration treatment market size is expected to grow to $14.3 billion in 2027 at a CAGR of 11.0%.
Read More On The Macular Degeneration Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report
Major competitors in the Macular Degeneration Treatment market include Novartis AG, Bausch Health Companies Inc., Regenxbio Inc., F Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., GlaxoSmithKline plc, Bayer AG, Neurotech Pharmaceuticals Inc., Ophthotech Corporation, StemCells Inc., Pfizer Inc., Santen Pharmaceuticals, Alimera Sciences Inc., Aerie Pharmaceutical Inc., Panoptica, Allergan Inc., Valeant Pharmaceuticals, and Rxi Pharmaceuticals Inc.
The Macular Degeneration Treatment market is segmented -
By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
By Route of Administration: Oral, Injectable, Other Route of Administration
By Types: Wet Macular Degeneration, Dry Macular Degeneration
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Macular Degeneration Treatment market.
Request A Free Sample Of The Macular Degeneration Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp
Macula refers to the central portion of the retina, a light-sensitive layer of tissue at the back of the eye. The macula is responsible for central vision. Degeneration of the macula, which affects the central part of the retina (the macula) and results in distortion or loss of central vision, occurs most commonly after the age of 60 and is referred to as age-related macular generation (AMD). The macular degeneration treatment is used to treat macular degeneration eye disease and slow the disease and prevent severe loss of vision.
The Table Of Content For The Macular Degeneration Treatment Market Include:
1. Executive Summary
2. Macular Degeneration Treatment Market Characteristics
3. Macular Degeneration Treatment Market Trends And Strategies
4. Macular Degeneration Treatment Market - Macro Economic Scenario
5. Macular Degeneration Treatment Market Size And Growth
……
26. Africa Macular Degeneration Treatment Market
27. Macular Degeneration Treatment Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Macular Degeneration Treatment Market
29. Macular Degeneration Treatment Market Future Outlook and Potential Analysis
30. Appendix
The "Global Macular Degeneration Treatment Market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Macular Degeneration Treatment Global Market Forecast 2023-2032 : By Industry Analysis, Size, Share, Major Players Are - Novartis AG, Regenxbio Inc., GlaxoSmithKline plc, Bayer AG, StemCells Inc. here
News-ID: 2986051 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Degeneration
Emerging Cartilage Degeneration Market Trends: Innovative Products Transforming …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Cartilage Degeneration Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for cartilage degeneration has witnessed robust growth. It is projected to rise from $12.63 billion in 2024 to $13.4 billion in 2025, with a compound annual growth rate (CAGR) of 6.2%. Factors…
Growing Retinal Disorder Incidence Propels Macular Degeneration Treatment Market …
The Macular Degeneration Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Macular Degeneration Treatment Market Size and Its Estimated Growth Rate?
Recent years have witnessed significant growth in the macular degeneration treatment market. The market size is projected to increase from…
Top Factor Driving Macular Degeneration Treatment Market Growth in 2025: Growing …
Which drivers are expected to have the greatest impact on the over the macular degeneration treatment market's growth?
The growth of the macular degeneration treatment market is poised to be catalyzed by the escalating issue of retinal disorders. These disorders compromise a crucial tissue and consequently disrupt the way our eyes process visual input, often resulting in blank or warped vision. For instance, data gathered by the American Academy of Ophthalmology…
Global Age-Related Macular Degeneration Market Forecast Report by Disease Type ( …
Age-Related Macular Degeneration Market Analysis
The global age-related macular degeneration (AMD) market is projected to reach USD 19.53 billion by 2032, up from USD 10.68 billion in 2023, with a compound annual growth rate (CAGR) of 6.94% from 2024 to 2032. The market's expansion is driven by an aging population susceptible to macular cell damage due to changes in retinal structure and blood flow. Additional factors contributing to this growth include…
Exploring Cartilage Degeneration Market Trends 2024
The cartilage degeneration market size has grown strongly in recent years. It will grow from $11.88 billion in 2023 to $12.63 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to aging population, joint injuries, obesity epidemic, sports injuries, limited self-repair capacity.
The cartilage degeneration market size is expected to see strong growth in the next few…
Wet Age-Related Macular Degeneration Pipeline 2024
DelveInsight's, "Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight, 2024," report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Wet Age-Related Macular Degeneration (Wet-AMD) pipeline landscape. It covers the Wet Age-Related Macular Degeneration pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key…
